|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Total Current Assets | |||||||
| Cash held in Trust Account | |||||||
| Total Assets | |||||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT | |||||||
| Current Liabilities | |||||||
| Accounts payable and other accrued expenses | |||||||
| Advance from related parties | |||||||
| Convertible note—related party, net of debt discount | |||||||
| Accrued offering cost | |||||||
| Convertible note | |||||||
| Total Current Liabilities | |||||||
| Warrant liability | |||||||
| Conversion option liability | |||||||
| Deferred underwriting fee payable | |||||||
| Total Liabilities | |||||||
| Class A ordinary shares subject to possible redemption, 43,067,606 at $10.00 per share redemption value as of June 30, 2022 and December 31, 2021, respectively | |||||||
| Shareholders' Equity (Deficit) | |||||||
| Preferred shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding | |||||||
| Common stock, value | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Shareholders' Deficit | |||||||
| Common Class A | |||||||
| Common Class B | |||||||
| Total Shareholders' Deficit | |||||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT. |
Loading...